참고문헌
- World Health Organization. Global hepatitis report, 2017. Geneva: World Health Organization, 2017.
- Smith S, Harmanci H, Hutin Y, Hess S, Bulterys M, Peck R, et al. Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017. JHEP Rep 2019;1:81-9. https://doi.org/10.1016/j.jhepr.2019.04.002
- Hutin YJ, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc 2018;21(Suppl 2):e25050. https://doi.org/10.1002/jia2.25050
- Chang MH. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience. Clin Liver Dis 2010;14:521-30. https://doi.org/10.1016/j.cld.2010.05.010
- Hsu SC, Chang MH, Ni YH, Hsu HY, Lee CY. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr 1993;16:66-9. https://doi.org/10.1097/00005176-199301000-00012
- Ni YH, Chen DS. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris) 2010;58:296-300. https://doi.org/10.1016/j.patbio.2009.11.002
- Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28:126-35. https://doi.org/10.1093/epirev/mxj010
- Nayagam S, Thursz M. Strategies for global elimination of chronic HBV infection: 2019 update. Curr Hepatol Rep 2019;18:300-9. https://doi.org/10.1007/s11901-019-00478-w
- Su WJ, Chen SF, Yang CH, Chuang PH, Chang HF, Chang MH. The impact of universal infant hepatitis B immunization on reducing the hepatitis B carrier rate in pregnant women. J Infect Dis 2019;220:1118-26. https://doi.org/10.1093/infdis/jiy706
- Lin CC, Hsieh HS, Huang YJ, Huang YL, Ku MK, Hung HC. Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health 2008;8:49. https://doi.org/10.1186/1471-2458-8-49
- Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012;142:773-81.e2. https://doi.org/10.1053/j.gastro.2011.12.035
- Chen SC, Toy M, Yeh JM, Wang JD, Resch S. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics 2013;131:e1135-43. https://doi.org/10.1542/peds.2012-1262
- Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7. https://doi.org/10.1002/jmv.1890180402
- Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9. https://doi.org/10.1002/jmv.1890340205
- Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in taiwan. JAMA 1996;276:906-8. https://doi.org/10.1001/jama.1996.03540110060032
- Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800. https://doi.org/10.7326/0003-4819-135-9-200111060-00009
- Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-93. https://doi.org/10.1053/j.gastro.2007.02.055
- Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012;57:730-5. https://doi.org/10.1016/j.jhep.2012.05.021
- Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, et al. Continuing decrease in hepatitis B virus infection 30 years after initiation of infant vaccination program in Taiwan. Clin Gastroenterol Hepatol 2016;14:1324-30. https://doi.org/10.1016/j.cgh.2016.04.030
- World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Gevana: World Health Organization, 2016.
- Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008;197:1419-26. https://doi.org/10.1086/587695
- Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987;111:34-9. https://doi.org/10.1016/S0022-3476(87)80338-4
- Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001;139:349-52. https://doi.org/10.1067/mpd.2001.116277
- Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004;39:58-63. https://doi.org/10.1002/hep.20006
- Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. JAMA 2013;310:974-6. https://doi.org/10.1001/jama.2013.276701
- Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64:2377-80. https://doi.org/10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8
- Chang MH, You SL, Chen CJ, Liu CJ, Lai MW, Wu TC, et al. Long-term effects of hepatitis B immunization of infants in preventing liver cancer. Gastroenterology 2016;151:472-80.e1. https://doi.org/10.1053/j.gastro.2016.05.048
- Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9. https://doi.org/10.1056/NEJM199706263362602
- Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348-55. https://doi.org/10.1093/jnci/djp288
- Wen WH, Chang MH, Zhao LL, Ni YH, Hsu HY, Wu JF, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013;59:24-30. https://doi.org/10.1016/j.jhep.2013.02.015
- Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998;133:374-7. https://doi.org/10.1016/S0022-3476(98)70272-0
- Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67:1560-99. https://doi.org/10.1002/hep.29800
- European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370-98. https://doi.org/10.1016/j.jhep.2017.03.021
- Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1-98.
- Chen HL, Wen WH, Chang MH. Management of pregnant women and children: focusing on preventing mother-to-infant transmission. J Infect Dis 2017;216(suppl_8):S785-91. https://doi.org/10.1093/infdis/jix429
- Song J, Yang F, Wang S, Tikande S, Deng Y, Tang W, et al. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat 2019;26:397-406.
- Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015;62:375-86. https://doi.org/10.1002/hep.27837
- Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016;374:2324-34. https://doi.org/10.1056/NEJMoa1508660
- Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med 2018;378:911-23. https://doi.org/10.1056/NEJMoa1708131
- Wen WH, Huang CW, Chie WC, Yeung CY, Zhao LL, Lin WT, et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology 2016;64:1451-61. https://doi.org/10.1002/hep.28589
- Chang KC, Chang MH, Lee CN, Chang CH, Wu JF, Ni YH, et al. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Aliment Pharmacol Ther 2019;50:306-16. https://doi.org/10.1111/apt.15321
피인용 문헌
- Human hepatitis viruses-associated cutaneous and systemic vasculitis vol.27, pp.1, 2020, https://doi.org/10.3748/wjg.v27.i1.19
- Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 Alleles With the Long-Term and Booster Immune Responses of Young Adults Vaccinated Against the Hepatitis B Virus as Neonates vol.12, 2021, https://doi.org/10.3389/fimmu.2021.710414